Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Vifor Pharma (Switzerland)

InstitutionResearch output, impact & collaborations

Vifor Pharma (Switzerland) is a research organisation in Glattbrugg, CH. OpenAlex records 964 works and 58,702 citations for it. 245 researchers list it as their most recent affiliation.

964
Works
58,702
Citations
245
Researchers
15
Avg h-index

How has Vifor Pharma (Switzerland)'s publication output changed over time?

ScholarIQpublication output · 2013–2026

Output grew0% over the shown period — from 1 works in 2013 to 1 in 2026.

1
1
2
1
1
1
2
1
1
201320142015201620172020202120222026

Who are the most-cited researchers behind Vifor Pharma (Switzerland)?

ScholarIQtop researchers by citations
1
Antonio Ramírez de Arellano · Diabetes Management and Research
64 works492 citations

What are the most-cited papers on Vifor Pharma (Switzerland)?

ScholarIQmost cited works
The Economic Burden of Insulin-Related Hypoglycemia in Spain
Witesh Parekh, Nicki Hoskins, James Baker‐Knight, Antonio Ramírez de Arellano, Pedro Mezquita Raya
Diabetes Therapy. 201734 CitationsOPEN ACCESS
The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland
Thomas Ward, Tray Brown, Ruth D. Lewis, Melodi Koşaner Kließ, Antonio Ramírez de Arellano, Carol Moreno Quinn
PharmacoEconomics - Open. 202232 CitationsOPEN ACCESS
Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising <scp>AFFIRM‐AHF</scp>
Phil McEwan, Piotr Ponikowski, Jason A. Davis, Giuseppe Rosano, Andrew J.S. Coats, Fabio Dorigotti, Donal O'Sullivan, Antonio Ramírez de Arellano, Ewa A. Jankowska
European Journal of Heart Failure. 202131 CitationsOPEN ACCESS
Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin
Antonio Pérez, Pedro Mezquita Raya, Antonio Ramírez de Arellano, Teresa Briones, Barnaby Hunt, William J. Valentine
Diabetes Therapy. 201530 CitationsOPEN ACCESS
Self-Reported Frequency and Impact of Hypoglycemic Events in Spain
Domingo Orozco‐Beltrán, Pedro Mezquita‐Raya, Antonio Ramírez de Arellano, Manuel Galán
Diabetes Therapy. 201430 CitationsOPEN ACCESS

How much of the research on Vifor Pharma (Switzerland) is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
73%
Green
0%
Hybrid
18%
Bronze
9%
Closed
0%

Related on ScholarIQ

Iron Metabolism and Disorders
Top Topic
Erythropoietin and Anemia Treatment
Top Topic
Hemoglobinopathies and Related Disorders
Top Topic
Potassium and Related Disorders
Top Topic
Dermatology and Skin Diseases
Top Topic
Parathyroid Disorders and Treatments
Top Topic
470M+ articles · free account